文献速递流行病学与生物统计临床试验与 GCP

重症ARDS早期ECMO的贝叶斯事后分析:死亡获益的后验概率

Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial.
PubMed 文献 · JAMA · 2018-01-01

该研究对EOLIA随机临床试验中249例极重度ARDS患者数据进行事后贝叶斯分析,比较早期ECMO与常规肺保护性通气(可补救ECMO)。在不同先验假设下,早期ECMO降低60天死亡风险的后验概率为88%至99%,但达到预设RR<0.67或ARR≥20%的概率较低。

要点

  • 早期ECMO降低60天死亡风险的后验概率在88%至99%之间,取决于先验假设。
  • 达到预设RR<0.67的后验概率为0%至48%,达到ARR≥20%的概率为0%至4%。
  • 贝叶斯分析可补充传统显著性检验,帮助解读不确定的试验证据。

核心结论

  • 在多种先验假设下,早期ECMO对极重度ARDS患者60天死亡风险降低的后验概率较高,但达到预设大效应量的概率较低。

研究设计与样本

  • 对EOLIA随机临床试验进行事后贝叶斯分析,纳入249例极重度ARDS患者,早期ECMO组124例,常规肺保护性通气组125例。

主要发现

  • 微信息先验下,60天死亡RR<1的后验概率为96%(RR 0.78,95%CrI 0.56-1.04),RR<0.67的概率为18%,ARR≥2%的概率为92%,ARR≥20%的概率为2%。
  • 中度积极先验下,RR为0.78(95%CrI 0.63-0.96),RR<1的概率为99%,RR<0.67的概率为8%,ARR≥2%的概率为97%,ARR≥20%的概率为0%。
  • 强怀疑先验下,RR为0.88(95%CrI 0.71-1.09),RR<1的概率为88%,RR<0.67的概率为0%,ARR≥2%的概率为78%,ARR≥20%的概率为0%。
  • 基于既往研究的先验下,RR为0.71(95%CrI 0.55-0.94),RR<1的概率为99%,RR<0.67的概率为48%,ARR≥2%的概率为98%,ARR≥20%的概率为4%。

临床怎么用

  • 贝叶斯事后分析可提供不同先验假设下的死亡获益后验概率,辅助临床医生在证据不确定时解读ECMO疗效。

局限性

  • 该分析为事后贝叶斯分析,结果依赖于所选择的先验分布假设。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Bayesian analysis of clinical trial data may provide useful information to aid in study interpretation, especially when trial evidence suggests that the benefits of an intervention are uncertain, such as in a trial that evaluated early extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS). OBJECTIVE: To demonstrate the potential utility of Bayesian analyses by estimating the posterior probability, under various assumptions, that early ECMO was associated with reduced mortality in patients with very severe ARDS in a randomized clinical trial (RCT). DESIGN AND EVIDENCE: A post hoc Bayesian analysis of data from an RCT (ECMO to Rescue Lung Injury in Severe ARDS [EOLIA]) that included 249 patients with very severe ARDS who had been randomized to receive early ECMO (n = 124; mortality at 60 days, 35%) vs initial conventional lung-protective ventilation with the option for rescue ECMO (n = 125, mortality at 60 days, 46%). The trial was designed to detect an absolute risk reduction (ARR) of 20%, relative risk (RR) of 0.67. Statistical prior distributions were specified to represent varying levels of preexisting enthusiasm or skepticism for ECMO and by Bayesian meta-analysis of previously published studies (with downweighting to account for differences and quality between studies). The RR, credible interval (CrI), ARR, and probability of clinically important mortality benefit (varying from RR less than 1 to RR less than 0.67 and ARR from 2% or more to 20% or more) were estimated with Bayesian modeling. FINDINGS: Combining a minimally informative prior distribution with the findings of the EOLIA trial, the posterior probability of RR less than 1 for mortality at 60 days after randomization was 96% (RR, 0.78 [95% CrI, 0.56-1.04]); the posterior probability of RR less than 0.67 was 18%, the probability of ARR of 2% or more was 92%, and the probability of ARR of 20% or more was 2%. With a moderately enthusiastic prior, equivalent to information from a trial of 264 patients with an RR of 0.78, the estimated RR was 0.78 (95% CrI, 0.63-0.96), the probability of RR less than 1 was 99%, the probability of RR less than 0.67 was 8%, the probability of ARR of 2% or more was 97%, and the probability of ARR of 20% or more was 0%. With a strongly skeptical prior, equivalent to information from a trial of 264 patients with an RR of 1.0, the estimated RR was 0.88 (95% CrI, 0.71-1.09), the probability of RR less than 1 was 88%, the probability of RR less than 0.67 was 0%, the probability of ARR of 2% or more was 78%, and the probability of ARR of 20% or more was 0%. If the prior was informed by previous studies, the estimated RR was 0.71 (95% CrI, 0.55-0.94), the probability of RR less than 1 was 99%, the probability of RR less than 0.67 was 48%, the probability of ARR of 2% or more was 98%, and the probability of ARR of 20% or more was 4%. CONCLUSIONS AND RELEVANCE: Post hoc Bayesian analysis of data from a randomized clinical trial of early extracorporeal membrane oxygenation compared with conventional lung-protective ventilation with the option for rescue extracorporeal membrane oxygenation among patients with very severe acute respiratory distress syndrome provides information about the posterior probability of mortality benefit under a broad set of assumptions that may help inform interpretation of the study findings.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Goligher EC, Tomlinson G, Hajage D, et al. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial. JAMA. 2018. PMID: 30347031. doi:10.1001/jama.2018.14276

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。